Lennham publishes manuscript detailing the nonclinical PK and safety evaluation of d9-caffeine in Food and Chemical Toxicology
Read the manuscript here.
Previous
Previous
Lennham Pharmaceuticals Announces Issuance of U.S. Patent Covering Methods of Administering Psilocybin and Psilocin
Next
Next